Baird Financial Group’s Idexx Laboratories IDXX Stock Holding History

Baird Financial Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$46.4M	Buy	82,535 +32,384	+65%	+$20.8M	0.07%	182
2025 Q4	$33.9M	Sell	50,151 -375	-0.7%	-$255K	0.05%	239
2025 Q3	$32.3M	Buy	50,526 +123	+0.2%	+$74.7K	0.05%	263
2025 Q2	$27M	Buy	50,403 +1,080	+2%	+$516K	0.05%	297
2025 Q1	$20.7M	Sell	49,323 -114,022	-70%	-$49.5M	0.04%	342
2024 Q4	$67.5M	Sell	163,345 -46,998	-22%	-$20.6M	0.13%	140
2024 Q3	$106M	Sell	210,343 -22,984	-10%	-$11.2M	0.21%	96
2024 Q2	$114M	Sell	233,327 -11,901	-5%	-$5.97M	0.24%	85
2024 Q1	$132M	Sell	245,228 -29,414	-11%	-$16.1M	0.28%	77
2023 Q4	$152M	Sell	274,642 -4,981	-2%	-$2.34M	0.35%	56
2023 Q3	$122M	Buy	279,623 +8,898	+3%	+$4.44M	0.33%	65
2023 Q2	$136M	Buy	270,725 +38,155	+16%	+$18.3M	0.36%	56
2023 Q1	$116M	Buy	232,570 +1,367	+0.6%	+$654K	0.29%	69
2022 Q4	$94.3M	Sell	231,203 -2,687	-1%	-$1.04M	0.25%	85
2022 Q3	$76.2M	Buy	233,890 +53,481	+30%	+$19.6M	0.22%	103
2022 Q2	$63.3M	Buy	180,409 +1,672	+0.9%	+$682K	0.18%	133
2022 Q1	$97.8M	Buy	178,737 +2,522	+1%	+$1.33M	0.24%	84
2021 Q4	$116M	Sell	176,215 -4,560	-3%	-$2.86M	0.27%	83
2021 Q3	$112M	Sell	180,775 -26,125	-13%	-$17.6M	0.29%	78
2021 Q2	$131M	Sell	206,900 -1,454	-0.7%	-$803K	0.34%	60
2021 Q1	$102M	Sell	208,354 -10,579	-5%	-$5.3M	0.29%	76
2020 Q4	$109M	Sell	218,933 -50,220	-19%	-$22.5M	0.33%	68
2020 Q3	$106M	Sell	269,153 -13,278	-5%	-$4.91M	0.36%	56
2020 Q2	$93.2M	Buy	282,431 +23,032	+9%	+$6.67M	0.35%	57
2020 Q1	$62.8M	Sell	259,399 -13,175	-5%	-$3.44M	0.29%	76
2019 Q4	$71.2M	Sell	272,574 -9,342	-3%	-$2.46M	0.26%	101
2019 Q3	$76.7M	Sell	281,916 -1,596	-0.6%	-$444K	0.3%	79
2019 Q2	$78.1M	Buy	283,512 +4,819	+2%	+$1.19M	0.3%	71
2019 Q1	$62.3M	Buy	278,693 +4,918	+2%	+$1.02M	0.36%	66
2018 Q4	$50.9M	Buy	273,775 +74,205	+37%	+$15.2M	0.35%	70
2018 Q3	$49.7M	Buy	199,570 +1,388	+0.7%	+$337K	0.31%	86
2018 Q2	$43.2M	Buy	198,182 +58,455	+42%	+$12M	0.29%	95
2018 Q1	$26.7M	Sell	139,727 -3,447	-2%	-$636K	0.19%	154
2017 Q4	$22.4M	Sell	143,174 -1,290	-0.9%	-$203K	0.16%	169
2017 Q3	$22.5M	Sell	144,464 -4,326	-3%	-$684K	0.17%	159
2017 Q2	$24M	Sell	148,790 -140,944	-49%	-$22.9M	0.19%	148
2017 Q1	$44.8M	Sell	289,734 -79,302	-21%	-$10.9M	0.36%	69
2016 Q4	$43.3M	Sell	369,036 -150,479	-29%	-$17.2M	0.38%	64
2016 Q3	$58.6M	Sell	519,515 -5,178	-1%	-$546K	0.52%	35
2016 Q2	$48.7M	Buy	524,693 +16,821	+3%	+$1.44M	0.45%	56
2016 Q1	$39.8M	Sell	507,872 -10,734	-2%	-$773K	0.38%	71
2015 Q4	$37.8M	Buy	518,606 +136,418	+36%	+$9.73M	0.38%	67
2015 Q3	$28.4M	Buy	382,188 +375,594	+5,696%	+$26.9M	0.3%	94
2015 Q2	$423K	Buy	+6,594	New	+$456K	﹤0.01%	1020

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baird Financial Group's IDXX Position: Q1 2026 in Review

Baird Financial Group increased its Idexx Laboratories (IDXX) stake by 65% in Q1 2026, buying an estimated $20.8M and bringing the position to 82,535 shares worth $46.4M. The position accounts for 0.07% of the portfolio, ranked #182.

Baird Financial Group first reported a position in IDXX in Q2 2015 and has held it in 44 quarters since. The position peaked at $152M in Q4 2023. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Baird Financial Group held 82,535 shares of Idexx Laboratories worth $46.4M as of Q1 2026.
Baird Financial Group bought 32,384 Idexx Laboratories shares in Q1 2026, an estimated $20.8M.
Idexx Laboratories made up 0.07% of Baird Financial Group's portfolio in Q1 2026, its #182 holding.
Baird Financial Group first reported a position in Idexx Laboratories in Q2 2015 and has held it in 44 quarters since.
Baird Financial Group's Idexx Laboratories position peaked at $152M in Q4 2023.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.